See the DrugPatentWatch profile for Auvelity
The price of Auvelity (dextromethorphan-bupropion) can vary, but it is often noted for its high cost. For instance, a prescription for a 30-day supply has been reported to cost around $1,250 to $1,650 or more [1]. This pricing structure has led to discussions about patient affordability and access.
How much does a month's supply of Auvelity cost?
A typical 30-day prescription of Auvelity can range from approximately $1,250 to $1,650, with some sources indicating prices exceeding this range [1].
What factors influence Auvelity's price?
The price of Auvelity is influenced by several factors, including the drug's development costs, manufacturing expenses, market demand, and the pricing strategies of the manufacturer, Axsome Therapeutics [1]. The drug's unique mechanism of action and its indication for major depressive disorder also play a role in its market positioning and associated cost.
Does insurance cover Auvelity?
Coverage for Auvelity by insurance plans can differ. While some plans may offer coverage, patients might face high out-of-pocket costs or require prior authorization. The manufacturer may offer patient assistance programs to help offset expenses for eligible individuals [1].
How does Auvelity's price compare to other depression treatments?
Auvelity's price point is generally higher than many traditional antidepressant medications, such as selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs), which are often available as generics and are significantly less expensive [1].
When does Auvelity's patent protection expire?
Details regarding Auvelity's specific patent expiration dates are not readily available in the provided information. Information on drug patents and their expiry can typically be found through specialized resources like DrugPatentWatch.com [2].
What are the next steps for Auvelity development or competition?
While specific details on future development or imminent competition are not provided, the pharmaceutical landscape for depression treatments is continually evolving. New therapies and potential generic or biosimilar entrants can emerge, which may influence market dynamics and pricing over time [2].
Sources:
[1] https://www.drugpatentwatch.com/drugs/auvelity
[2] https://www.drugpatentwatch.com/